Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical impact of the PAI-1 4G/5G polymorphism in Chinese patients with venous thromboembolism

14 Nov 2022

Abstract excerpt

BACKGROUND: Venous thromboembolism (VTE) is a life-threatening cardiovascular syndrome that characterized by the imbalance of hemostasis and thrombosis and the formation of thrombi in the blood vessels. The aim of this study was to elucidate the clinical impact of the PAI-1 4G/5G polymorphism in Chinese patients with VTE. METHODS: A total of 169 subjects (89 VTE, 10 hyperbilirubinemia, 10 hyperlipidemia and 60...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Coagulation and Thrombosis Mechanisms
Share to Platelet Disorders and Treatments
Share to Protease and Inhibitor Mechanisms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36376889
DOI: 10.1186/s12959-022-00430-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical impact of the PAI-1 4G/5G polymorphism in Chinese patients with venous thromboembolismPMID 36376889Read ↗

Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and risk of venous thromboembolism: a meta-analysis.Semantic proximity Read ↗

Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphisms and risk of venous thromboembolism - a meta-analysis and systematic review.Semantic proximity Read ↗

Investigation of Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G promoter polymorphism in Indian venous thrombosis patients: A case-control study.Semantic proximity Read ↗

Combined Effect of MTHFR C677T and PAI-1 4G/5G Polymorphisms on the Risk of Venous Thromboembolism in Chinese Lung Cancer Patients.Semantic proximity Read ↗

Association of β-fibrinogen polymorphisms and venous thromboembolism risk: A PRISMA-compliant meta-analysis.Semantic proximity Read ↗

Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and venous thrombosisSemantic proximity Read ↗

Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and venous thrombosis. A meta-analysis.Semantic proximity Read ↗

Influence of decreased fibrinolytic activity and plasminogen activator inhibitor-1 4G/5G polymorphism on the risk of venous thrombosis.Semantic proximity Read ↗

[Advances in the genetics of venous thromboembolic disease].Semantic proximity Read ↗

The genetics of venous thromboembolism. A meta-analysis involving approximately 120,000 cases and 180,000 controls.Semantic proximity Read ↗

Influence of the 4G/5G polymorphism of plasminogen activator inhibitor-1 gene in acute unprovoked deep vein thrombosis and residual vein thrombosis.Semantic proximity Read ↗

The effect of the plasminogen activator inhibitor-1 4G/5G polymorphism on the Venous thromboembolism risk after total knee arthroplastySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.